Group items tagged

Market Overview: Next-generation antibody therapeutics includes the use of new improvised therapeutic antibody to form innovative medicines for treating various diseases. Next-generation antibody therapeutics is developed clinically by pharmaceutical and biotechnology companies for several diseases. The Next Generation Antibody Therapeutics Market size was worth $ XX million in 2018 and is forecasted to reach $ XX million by 2026, expected to grow at a high CAGR during the forecast period 2019-2026. Market Dynamics: The Next Generation Antibody Therapeutics Market is growing due to several factors such as rising incidence of chronic diseases, increasing emergence of antibody technology, new drug discovery, large number of government initiatives, and growing research and development activities for new therapies. Rising prevalence of chronic disease such as cancer, asthma, diabetes and COPD are boosting the growth of the next generation antibody therapeutics market. For instance, according to National Cancer Institute in 2018, in United States, an estimated 1,735,350 new cases of cancer will be diagnosed and 609,640 people will die from the disease. The development of next-generation monoclonal antibodies has expanded beyond oncology into all therapeutic areas. For instance, ADCs were initially focused primarily on cancer, but Genentech has applied to infectious diseases, leading to the discovery and development of THIOMAB antibiotic conjugates (TACs) for the treatment of methicillin-resistant Staphylococcus aureus (MRSA). The technological advancements in antibody therapeutics have led to the development of more efficient antibody therapeutics, hence, driving the growth in the next-generation antibody therapeutics market. However, stringent government regulation, high cost and time required for research and development activities are some of the factors hindering the growth for global next-generation antibody therapeutics market. Market Segmentation: Based o

Market Overview: Skin substitutes are natural, synthetic or biosynthetic materials, used to cover large wounds to restore at least some of the functions of the skin. Skin substitutes provides temporary or permanent wound closure and protect the wound from infection, further damage and water loss, and reduce pain. They also facilitate the growth of the normal skin over the wound. Skin substitutes provide a permanent solution and are used in the treatment of conditions like burns, trauma wounds, diabetes or venous ulcers, where skin grafts may not be possible. Market Dynamics: Rising chronic skin diseases is expected to drive the skin substitutes market. For instance, according to the global burden of disease study 2013, Skin conditions contributed around 1.79% to the global disease burden. According to the World Health Organization, about 132,000 melanoma skin cancers occur each year worldwide. Thus, the rising chronic diseases is increasing the demand for skin substitutes in the forecast period. Rising prevalence of diabetes is expected to boost the market. This is owing to the risk of developing a diabetic foot ulcer over the period of time in diabetic patients. For instance, WHO has reported that the incidence of diabetes for all age-groups worldwide was estimated to be 2.8% in 2000 and 4.4% in 2030. The total number of people with diabetes is anticipated to rise from 171 million in 2000 to 366 million in 2030. Thus, as a consequence, the prevalence of diabetes related complications are expected to increase over the forecast period. There are several limitations to the commercially available skin substitutes, like reduced vascularization, poor mechanical integrity, failure to integrate, scarring, and immune rejection. Market Segmentation: Rise in preference for acellular skin substitutes to implant-based skin surgery is expected to drive the growth of the skin substitutes market. For instance, the American Society of Plastic Surgeons in 2012, reported that

North America dominated the market in 2013 and will continue to drive and dominate it by 2018. However, the market share of this region will decrease to 34.5%, primarily due to the sequestration cuts announced in the U.S., which have resulted in lower investments from the government in research activities supporting proteomics. At the same time, Asia and Latin America are poised to grow at a CAGR of 17% to 22% in the forecast period; this growth is largely driven by the growing research base in these regions and the increasing pharmaceutical research related to drug discovery and drug development, and diagnostics product development activities in these regions.

Creative Animodel developing some animodels after researching disease in human bodies. Our scientists are researching over a year in different diseases and biological conditions of human daises and introducing some species to experiment over it by injecting and removing foreign biological materials. All the models helping medical science a lot to improve further studied over it.

Worksure delivers effective and successful training programs for Pre-clinical & Clinical scientific research, Medical Writing, Marketing and Sales personnel.

Teen alcohol abuse is on the rise and has been for quite a while. This has allowed researchers to document the health risks associated with teen alcohol abuse…

Teen alcohol abuse is on the rise and has been for quite a while. This has allowed researchers to document the health risks associated with teen alcohol abuse…

Patient Monitoring Devices Market research report categorizes the global market of healthcare monitoring devices or equipments on the basis of Trends & Competitive Analysis.

Patient Monitoring Devices Market research report categorizes the global market of healthcare monitoring devices or equipments on the basis of Trends & Competitive Analysis.

A social network for clinical researchers.

More than 300 scientists and researchers participating both in person and virtually agreed on a set of global research priorities.

Companion animals are domesticated or domestic-bred animals whose physical, emotional, behavioral and social needs can be readily met as companions in the home or a close daily relationship with humans. Companion animal health market mainly comprises of medicines, medicinal feed additives, and vaccines and caters to both foods producing and companion animals. China Companion Animal Health Market was worth US$ XX Million in 2019 and is expected to reach US$ XX Million by 2026, at a CAGR of XX% during the forecast period 2019-2026. Download Free Sample Report: https://www.datamintelligence.com/download-sample/china-companion-animal-health-market View Full Report Sample: https://www.datamintelligence.com/research-report/china-companion-animal-health-market

Chronic Immune Thrombocytopenia (chronic ITP) is an autoimmune disorder in which patients produce antiplatelet autoantibodies and specialized white blood cells that destroy their blood platelets and, in some cases, damage their megakaryocytes, causing a decrease in platelet production. The global chronic immune thrombocytopenia market size was worth $ XX billion in 2019 and is forecasted to reach $ XX billion by 2026, at a CAGR of XX% during the forecast period (2019-2026). View Full Report Sample: https://www.datamintelligence.com/research-report/chronic-immune-thrombocytopenia-market Download free Report Sample: https://www.datamintelligence.com/download-sample/chronic-immune-thrombocytopenia-market

[Price: $4650] [No of Pages - 383 ] Browse market tables and figures/charts on Minimally Invasive Surgical Instruments/Devices, Imaging & Visualization Systems & Medical Robotics Market research report will analyze the market potential for minimally-invasive and non-invasive surgery.

Myeloid leukemia therapeutics market research report evaluates the therapeutics market of acute myeloid leukemia in G8 countries with respect to the current and pipeline drugs and regimens.

[Price: $4650] [No of Slides - 140] Browse 11 tables and 44 figures/charts on Protein Engineering Market report categorizes the global market by products (Monoclonal Antibodies, Insulin Analog, Modified EPO), applications (Therapeutics, Diagnostics, Research), technology (Sequential Modification, Glycosylation & PEGylation) & by geography - forecasting - 2017

[No of Slides - 140] Browse 11 tables and 44 figures/charts on Protein Engineering Market report categorizes the global market by products (Monoclonal Antibodies, Insulin Analog, Modified EPO), applications (Therapeutics, Diagnostics, Research), technology (Sequential Modification, Glycosylation & PEGylation) & by geography - forecasting - 2017

The infection control market research reports suggest increased demand of disinfection products due to rise in surgical proceedings, chronic diseases, and increased number of aging population.

[Price: $4650] [No of Pages - 445] Browse 148 tables and 152 figures/charts on Endoscopy market research report provides comprehensive analysis on global market of endoscopy by products/devices, applications and technology.

Protein Engineering Market report categorizes the global market by products (Monoclonal Antibodies, Insulin Analog, Modified EPO), applications (Therapeutics, Diagnostics, Research), technology (Sequential Modification, Glycosylation & PEGylation) & by geography - forecasting - 2017

Chronic lymphocytic leukemia therapeutics market research report evaluates evaluates the market in G8 countries with respect to the current and pipeline drugs, regimens, analyzes geography; forecasting revenue, and trends.

[Price: $4650] [No of Pages - 195] Browse 101 tables and 6 figures/charts on Apheresis Market research report categorizes the global market into procedure, application, technology, product type and end-user.